You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR ETOPOSIDE PHOSPHATE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for ETOPOSIDE PHOSPHATE

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00002880 ↗	Etoposide in Treating Patients With Relapsed Non-Hodgkin's Lymphoma	Completed	National Cancer Institute (NCI)	Phase 2	1996-11-01	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of etoposide in treating patients with relapsed non-Hodgkin's lymphoma.
NCT00002880 ↗	Etoposide in Treating Patients With Relapsed Non-Hodgkin's Lymphoma	Completed	Alliance for Clinical Trials in Oncology	Phase 2	1996-11-01	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of etoposide in treating patients with relapsed non-Hodgkin's lymphoma.
NCT00002961 ↗	Chemotherapy With or Without Total-Body Irradiation Prior to Bone Marrow Transplantation in Treating Children With Acute Lymphoblastic Leukemia	Terminated	Children's Hospital of Philadelphia	Phase 3	1995-10-01	RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining chemotherapy with bone marrow transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more cancer cells. Radiation therapy uses high-energy x-rays to damage cancer cells. Combining chemotherapy, radiation therapy, and bone marrow transplantation may kill more cancer cells. PURPOSE: Randomized phase III trial to compare high-dose chemotherapy with or without total-body irradiation before bone marrow transplantation in treating children with acute lymphoblastic leukemia.
NCT00003064 ↗	Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal Cancer	Unknown status	National Cancer Institute (NCI)	Phase 1/Phase 2	1997-01-01	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy and kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of chemotherapy and autologous peripheral stem cell transplantation in treating patients with recurrent or persistent epithelial ovarian cancer, fallopian tube, or primary peritoneal cancer.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for ETOPOSIDE PHOSPHATE

Condition Name

Chart
Table

Condition Name for ETOPOSIDE PHOSPHATE
Intervention	Trials
Lymphoma	17
Leukemia	10
Neuroblastoma	7
Brain and Central Nervous System Tumors	6
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for ETOPOSIDE PHOSPHATE
Intervention	Trials
Lymphoma	41
Leukemia	27
Leukemia, Lymphoid	15
Hodgkin Disease	13
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for ETOPOSIDE PHOSPHATE

Trials by Country

Map
Table

Trials by Country for ETOPOSIDE PHOSPHATE
Location	Trials
United States	726
Canada	62
United Kingdom	28
Australia	26
Germany	12
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for ETOPOSIDE PHOSPHATE
Location	Trials
California	35
Texas	30
Ohio	27
Pennsylvania	25
Michigan	22
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for ETOPOSIDE PHOSPHATE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for ETOPOSIDE PHOSPHATE
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	23
Phase 2/Phase 3	2
[disabled in preview]	38
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for ETOPOSIDE PHOSPHATE
Clinical Trial Phase	Trials
Completed	34
Recruiting	21
Active, not recruiting	17
[disabled in preview]	11
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ETOPOSIDE PHOSPHATE

Sponsor Name

Chart
Table

Sponsor Name for ETOPOSIDE PHOSPHATE
Sponsor	Trials
National Cancer Institute (NCI)	46
Children's Oncology Group	8
City of Hope Medical Center	7
[disabled in preview]	6
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for ETOPOSIDE PHOSPHATE
Sponsor	Trials
Other	101
NIH	46
Industry	27
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.